E
GlucoTrack, Inc. GCTK
$0.3579 $0.00190.53%
Recommendation
Sell
Prev Close
$0.356
Volume
456,920
Avg Vol (90D)
2,534,506
Market Cap
$3.71M
Dividend & Yield
--
52-Week Range
$0.3067 - $99.00
P/E (TTM)
--
EPS (TTM)
-$55.35
My Lists My Alerts
Rating
Reward
E-
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
2/26/2025 - GuruFocus
Glucotrack appoints Umpierrez to Medical Advisory Board
2/26/2025 - The Fly
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
2/26/2025 - Globe Newswire
Glucotrack Prices $3 Million Public Offering to Fund Expansion
2/5/2025 - GuruFocus
Glucotrack announces pricing of $3M public offering
2/4/2025 - Seeking Alpha - Healthcare
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
2/4/2025 - GuruFocus
GlucoTrack prices offering of 2.6M shares of common stock at $1.15
2/4/2025 - The Fly
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
2/4/2025 - Globe Newswire
Glucotrack soars on completion of first human clinical study of continuous blood glucose monitor
2/4/2025 - Seeking Alpha - Healthcare
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous ...
2/4/2025 - GuruFocus
GlucoTrack announces completion of first in human clinical study of CGM
2/4/2025 - The Fly
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
2/4/2025 - Globe Newswire
GlucoTrack Inc trading halted, news pending
2/4/2025 - TipRanks Financial Blog
GlucoTrack Inc trading halted, news pending
2/4/2025 - The Fly
**GlucoTrack Announces Resignation of Chief Financial Officer and Appointment of Peter Wulff as Replacement**WASHINGTON, D.C. 2025 - GlucoTrack, Inc. (NASDAQ: GCTK) recently disclosed on January 27, 2025, that James Cardwell, the Chief Financial Offi
1/31/2025 - Ticker Report
Glucotrack to execute 1-for-20 reverse stock split
1/30/2025 - Seeking Alpha - Healthcare
Glucotrack to execute 1-for-20 reverse stock split
1/30/2025 - SeekingAlpha.com: All News
GlucoTrack announces 1-for-20 reverse stock split
1/30/2025 - The Fly
Glucotrack Announces Reverse Stock Split
1/30/2025 - GuruFocus
Glucotrack Announces Reverse Stock Split
1/30/2025 - Globe Newswire
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
1/29/2025 - GuruFocus
GlucoTrack appoints Wulff as Chief Financial Officer
1/29/2025 - TipRanks Financial Blog
GlucoTrack appoints Wulff as Chief Financial Officer
1/29/2025 - The Fly
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
1/29/2025 - Globe Newswire
How Is The Market Feeling About GlucoTrack?
1/22/2025 - Benzinga
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$13.08M
EBIT (TTM)
-$13.11M
Net Income (TTM)
-$14.92M
Balance Sheet
Total Assets (Q)
$826.00K
Total Debt (Q)
$2.26M
Total Liabilities (Q)
$4.85M
Book Value Per Share (Q)
-$13.94
Cash Flow
Cash from Operations (TTM)
-$11.40M
Cash from Investing (TTM)
-$104.00K
Cash from Financing (TTM)
$4.96M
Net Change in Cash (TTM)
-$6.54M
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 24 and 28 (est)
Price History
Loading...
Beta
0.37
7-Day Total Return
4.96%
30-Day Total Return
-80.42%
60-Day Total Return
-93.61%
90-Day Total Return
-98.99%
Year to Date Total Return
-94.37%
1-Year Total Return
-98.84%
2-Year Total Return
-99.09%
3-Year Total Return
-99.89%
5-Year Total Return
-99.94%
52-week Low
Mar 04, 2025 - $0.3067
52-week High
Apr 22, 2024 - $99.00
Valuation
Market Cap
$3.71M - Nano Cap
Enterprise Value
$5.62M
Price/Sales (TTM)
--
Price/Book (Q)
-0.03
Dividends and Shares
Shares Outstanding
279.70K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
glucotrack.com
Phone Number
201 842 7715
Address
301 Route 17 North
Rutherford, NJ 07070
Country
United States
Year Founded
2001
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack... more
NASDAQ 03/12/2025 3:57PM Eastern Quotes delayed
Weiss Ratings